March 2019 FDA Recall Pravastatin Sodium by Glenmark Pharmaceuticals Inc., Usa
D-1120-2019 - Presence Of Foreign Tablet

This Class II drug recall was voluntarily initiated by Glenmark Pharmaceuticals Inc., Usa on March 25, 2019 for the product Pravastatin Sodium. The FDA reported the reason for recall as presence of foreign tablet. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1120-2019

Reason for Recall
Presence Of Foreign Tablet: in a bottle of Pravastatin Sodium Tablets 20 mg.
Initiated
03-25-2019
Reported
04-17-2019
Quantity
2076 500-count Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Glenmark Pharmaceuticals Inc., USA
Nationwide in the USA
Pravastatin Sodium Tablets USP, 20 mg, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma zone SEZ, Pithampur, Dist-Dhar, Madhya Pradesh 454 775, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. NDC 68462-196-05

Batch or Lot Expiration Information

Lot# Lot 17181491 Exp. Aug. 2021